Related Experiment Video
Updated: Feb 28, 2026

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
Published on: May 28, 2017
Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases
Guillermo Rodríguez-Hernández1,2, Julia Hauer3, Alberto Martín-Lorenzo1,2
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus M. de Unamuno s/n, Salamanca, Spain.
Insights
ETV6-RUNX1 gene fusions in stem cells increase childhood leukemia risk after infections. KDM gene alterations drive leukemia development and RAG off-target cleavage, offering new therapeutic targets.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
- Genetics
Background:
- ETV6-RUNX1 fusion is linked to childhood leukemia, but most carriers don't develop it.
- Infection exposure is a suspected factor in leukemia development, suggested by time-space clusters.
- The genetic mechanisms linking preleukemic ETV6-RUNX1 and infection to leukemia are unclear.
Purpose of the Study:
- To investigate the mechanistic link between preleukemic ETV6-RUNX1 expression in hematopoietic stem cells and postnatal infections.
- To understand the genetic basis for the development of precursor B-cell acute lymphoblastic leukemia (pB-ALL) in ETV6-RUNX1 carriers.
- To identify molecular mechanisms driving clonal evolution from preleukemic to overt leukemia.
Main Methods:
- Developed an in vivo model to study ETV6-RUNX1 in hematopoietic stem/progenitor cells.
- Analyzed gene expression (Rag1/2) in murine preleukemic cells.
- Performed genomic alteration analysis in murine and human ETV6-RUNX1 pB-ALL.
- Investigated the role of KDM family genes, specifically KDM5C loss of function, and its effect on H3K4me3 and RAG2 interaction.
Main Results:
- ETV6-RUNX1 conferred a low risk of pB-ALL after pathogen exposure in the model, mirroring human incidence.
- Murine and human ETV6-RUNX1 pB-ALL showed high Rag1/2 expression and recurrent genomic alterations, particularly in KDM family genes.
- KDM5C loss of function increased H3K4me3 levels, facilitating RAG2 interaction and recombination activity.
Conclusions:
- Alterations in KDM family members are a disease-driving mechanism in ETV6-RUNX1-associated pB-ALL.
- These KDM alterations explain RAG off-target cleavage observed in human leukemia.
- The study elucidates the genetic basis for clonal evolution to pB-ALL post-infection and suggests novel therapeutic strategies.
Abstract:
ETV6-RUNX1 is associated with the most common subtype of childhood leukemia. As few ETV6-RUNX1 carriers develop precursor B-cell acute lymphocytic leukemia (pB-ALL), the underlying genetic basis for development of full-blown leukemia remains to be identified, but the appearance of leukemia cases in time-space clusters keeps infection as a potential causal factor. Here, we present in vivo genetic evidence mechanistically connecting preleukemic ETV6-RUNX1 expression in hematopoetic stem cells/precursor cells (HSC/PC) and postnatal infections for human-like pB-ALL. In our model, ETV6-RUNX1 conferred a low risk of developing pB-ALL after exposure to common pathogens, corroborating the low incidence observed in humans. Murine preleukemic ETV6-RUNX1 pro/preB cells showed high Rag1/2 expression, known for human ETV6-RUNX1 pB-ALL. Murine and human ETV6-RUNX1 pB-ALL revealed recurrent genomic alterations, with a relevant proportion affecting genes of the lysine demethylase (KDM) family. KDM5C loss of function resulted in increased levels of H3K4me3, which coprecipitated with RAG2 in a human cell line model, laying the molecular basis for recombination activity. We conclude that alterations of KDM family members represent a disease-driving mechanism and an explanation for RAG off-target cleavage observed in humans. Our results explain the genetic basis for clonal evolution of an ETV6-RUNX1 preleukemic clone to pB-ALL after infection exposure and offer the possibility of novel therapeutic approaches. Cancer Res; 77(16); 4365-77. ©2017 AACR.
More Related Videos
10:26In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
Non-LTR Retrotransposons
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...